Latest News

• share
• favorite_border

Recognized by annual learning and development benchmarking program for workforce development efforts

• share
• favorite_border

Mount Sinai Health System today announced that Crain’s New York Business Journal has named four of its leaders to its 2022 Notable Health Care Leaders list.

• share
• favorite_border

Lung disease caused by a new drug for cancers—including metastatic or advanced breast cancer—can be effectively treated using approaches that focus on early detection and prompt management, according to a study published in ESMO Open on August 11, 2022.

• share
• favorite_border

In a study published today in the Journal of General Internal Medicine, researchers at the Icahn School of Medicine at Mount Sinai paint a first-of-its-kind nationally representative portrait of the health care needs of older homebound Americans. An estimated 2 million strong and growing, this population has been at once invisible and extremely costly to the health care system. The researchers point to a home-based care model as the solution to better care and a more efficient allocation of health care dollars.

• share
• favorite_border

The Mount Sinai Health System announced today data from an innovative medical-legal pilot program that proactively identifies and provides free, civil legal services to patients in underserved communities who have unaddressed legal needs to improve their health outcomes.

• share
• favorite_border

Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 grant from Stand Up To Cancer® (SU2C) to explore therapeutic approaches to lung tumors with mutations in the KRAS gene, an undertaking that could have a significant impact for a large population of cancer patients who currently lack effective treatment options.

• share
• favorite_border

The Mount Sinai Health System has launched CastleVax, Inc. (“CastleVax”), a clinical-stage vaccine research and development company.

• share
• favorite_border

The Icahn School of Medicine at Mount Sinai announced today the appointment of three new Laureates as part of its Biomedical Laureates Program, furthering its institutional commitment to broadening diversity and mentorship opportunities.

• share
• favorite_border

Mount Sinai researchers have achieved an unprecedented understanding of the genetic and molecular machinery in human microglia—immune cells that reside in the brain—that could provide valuable insights into how they contribute to the development and progression of Alzheimer’s disease (AD). The team’s findings were published in Nature Genetics.

• share
• favorite_border

A team of researchers at the Icahn School of Medicine at Mount Sinai has identified a therapeutic target for the preservation and regeneration of beta cells (β cells)—cells in the pancreas that produce and distribute insulin.

• share
• favorite_border

The Jack Martin Fund (JMF) has built on its partnership with the Mount Sinai Health System to provide cutting-edge care and support to children with cancer through a new $3.5 million gift to The Mount Sinai Hospital to establish the Jack Martin Fund Child and Adolescent Imaging Center at Mount Sinai Kravis Children’s Hospital.

• share
• favorite_border

Mount Sinai Health System and Contessa, the leading comprehensive home-based care provider, announced the extension of their partnership combining Mount Sinai South Nassau’s home health agency into their existing joint venture. The new combination offers a full continuum of home-based care that includes home health, hospitalization at home, rehabilitation at home (in lieu of care at a skilled nursing facility) and palliative care at home. The home health agency will be called Mount Sinai at Home.

• share
• favorite_border

Mount Sinai study shows flavoprotein fluorescence could serve as new biomarker

• share
• favorite_border

Three Mount Sinai nurse leaders have been selected to be Fellows of the American Academy of Nursing (AAN) in the 2022 Class of Fellows.

• share
• favorite_border

In a race against time to cure childhood brain cancer, the leading cause of cancer deaths among children, Mount Sinai Kravis Children’s Hospital is forming the Mount Sinai Children’s Brain and Spinal Tumor Center.

• share
• favorite_border

The Mount Sinai Hospital’s Department of Geriatrics was ranked No. 1 in the nation by U.S. News & World Report for the third consecutive year. The Mount Sinai Hospital was also listed on the “Honor Roll” of the nation’s top 20 hospitals for the seventh year in a row.

• share
• favorite_border

Treating liver cancer tumors to shrink them in order to allow the patient to qualify for a liver transplant leads to excellent 10-year post-transplant outcomes, according to new Mount Sinai research published in JAMA Surgery. The results validate current national policies around transplant eligibility.

• share
• favorite_border

• share
• favorite_border

Mount Sinai Health System named winner of 2022 Carolyn Boone Lewis Equity of Care Award

• share
• favorite_border

Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are at significant risk for cardiovascular disease and stroke, according to new research from New York Eye and Ear Infirmary of Mount Sinai.

• share
• favorite_border

The growing incidence of a potentially cancer-causing liver disease in children is associated with prenatal exposure to several endocrine-disrupting chemicals, Mount Sinai researchers report.

• share
• favorite_border

Experts Encourage Rapid Genomic Screenings and Development of New Therapeutics for Drug-Resistant Pathogens to Address Emerging Global Health Concern

• share
• favorite_border

Mount Sinai-led researchers have shown that tiny, robust immune particles derived from the blood of a llama could provide strong protection against every COVID-19 variant, including Omicron, and 18 similar viruses.

• share
• favorite_border

Mount Sinai researchers have conducted one of the first studies to show the acute effect of obstructive sleep apnea on Alzheimer’s disease biomarkers, and the ability to even measure Alzheimer's disease biomarkers from blood.

• share
• favorite_border

Mount Sinai Health System is proud to announce that Kenneth L. Davis, MD, Chief Executive Officer, is among the 2022 class of Modern Healthcare’s 50 Most Influential Clinical Executives award.

• share
• favorite_border

Mount Sinai researchers have developed a machine learning algorithm that can determine if an individual has SARS-CoV-2 infections, the virus that causes COVID-19—with a high sensitivity and specificity—from the data collected by wearable devices.

• share
• favorite_border

Nina Bhardwaj, MD, PhD, Director of Immunotherapy at The Tisch Cancer Institute at Mount Sinai, has received the 2022 Lifetime Achievement in Cancer Research award from the American Association of Indian Scientists in Cancer Research (AAISCR).

• share
• favorite_border

Mount Sinai to lead discussions on transgender health, psychedelic therapeutics and long COVID at the 2022 Aspen Ideas: Health and Aspen Ideas Festival.

• share
• favorite_border

Mount Sinai researchers have for the first time identified genes that predict a good response to a vital new therapy for a blood cancer that can have serious side effects for some patients.

• share
• favorite_border

• share
• favorite_border

Mount Sinai researchers have developed a rapid blood assay that measures the magnitude and duration of someone’s immunity to SARS-CoV-2, the virus that causes COVID-19. This test will allow large-scale monitoring of the population’s immunity and the effectiveness of current vaccines to help design revaccination strategies for vulnerable immunosuppressed individuals, according to a study published in Nature Biotechnology in June.

• share
• favorite_border

• share
• favorite_border

Mount Sinai researchers have validated for the first time that a simple blood test called a liquid biopsy could be a better predictor of whether cancer immunotherapy will be successful for a patient with lung cancer than an invasive tumor biopsy procedure. Their study was published in the Journal of Experimental & Clinical Cancer Research in June.

• share
• favorite_border

Prolonged delays in breast cancer screening related to the COVID-19 pandemic have led to delayed diagnosis, poor health outcomes, and an increase in disparities. To address this, Mount Sinai Health System has launched “Mammogram May” to empower women to take charge of their breast health by scheduling an annual mammogram.

• share
• favorite_border

An advanced radiotherapy technique called radiation segmentectomy may be effective against very early to early-stage hepatocellular carcinoma (HCC), a type of liver cancer that cannot be treated surgically or thermally.

• share
• favorite_border

The National Institutes of the Health (NIH) has awarded researchers at the Icahn School of Medicine at Mount Sinai a four-year grant to study the role of the human microbiome in rheumatoid arthritis, systemic lupus, and other autoimmune diseases. The grant is part of the NIH’s Accelerating Medicines Partnership® Autoimmune and Immune-Mediated Diseases (AMP® AIM) program, which is designed to speed the discovery of new treatments and diagnostics. It will support the Microbiome Technology and Analytic Center Hub (Micro-TEACH), a multidisciplinary team of researchers at Icahn Mount Sinai and NYU Langone Health.

• share
• favorite_border

Mount Sinai Health System has appointed Bruce D. Gelb, MD, as Dean for Child Health Research at the Icahn School of Medicine at Mount Sinai.